- JP-listed companies
- SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
- Income statement
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (2395) Income statement
Market cap
¥46.8B
P/E ratio
13.4x
Provides drug development testing services to pharmaceutical companies and operates innovative intranasal drug delivery technology through spinout companies.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Revenue | 15,274 | 17,154 | 16,926 | 17,835 | 14,750 | 17,244 | 16,601 | 15,659 | 14,561 | 15,111 | 17,748 | 25,091 | 26,450 | 32,414 | 32,524 |
| Revenue growth (%) | - | ||||||||||||||
| Cost of revenue | - | - | - | 11,883 | 12,059 | 12,884 | 11,396 | 9,481 | 6,945 | 7,556 | 8,061 | 12,044 | 12,168 | 15,453 | 16,286 |
| Gross profit | - | - | - | 5,952 | 2,691 | 4,360 | 5,204 | 6,178 | 7,616 | 7,554 | 9,687 | 13,047 | 14,283 | 16,961 | 16,239 |
| Gross margin (%) | - | - | - | ||||||||||||
| Operating margin (%) | - | - | - | ||||||||||||
| Operating expenses | - | - | - | 6,589 | 6,554 | 6,153 | 5,902 | 5,348 | 5,387 | 5,025 | 5,492 | 7,801 | 10,120 | 13,976 | 13,585 |
| Operating income | - | - | - | -636 | -3,863 | -1,793 | -697 | 830 | 2,228 | 2,530 | 4,196 | 5,245 | 4,162 | 2,985 | 2,653 |
| Income before tax | -2,843 | -490 | -154 | 156 | -5,260 | -2,106 | -813 | 1,614 | 3,121 | 3,645 | 7,078 | 9,194 | 7,016 | 6,451 | 5,833 |
| Pretax margin (%) | -18.6 | -2.9 | -0.9 | 0.9 | -35.7 | -12.2 | -4.9 | 10.3 | 21.4 | 24.1 | 39.9 | 36.6 | 26.5 | 19.9 | 17.9 |
| Provision for income taxes | - | - | - | 992 | 903 | 128 | 2,013 | -308 | 415 | 498 | 1,016 | 1,709 | 1,457 | 1,149 | 1,713 |
| Effective tax rate (%) | - | - | - | ||||||||||||
| Net income | -5,950 | -3,446 | -403 | -1,386 | 2,647 | -892 | -3,521 | 1,959 | 2,648 | 3,678 | 7,167 | 6,060 | 5,531 | 4,925 | 4,567 |
| Earnings per share | -96.2 | -33.56 | -20.11 | -34.83 | 66.52 | -22.18 | -85.41 | 46.84 | 61.25 | 87.95 | 171.2 | 145.56 | 132.86 | 118.29 | 109.69 |
| Dividend per share | - | - | - | - | - | - | - | - | 5 | 20 | 40 | 50 | 50 | 50 | 50 |